Study of VLS-1488 for advanced cancers
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This early-phase study tests VLS-1488, a new cancer medicine, in people with advanced cancers that have limited treatment options. It may help by finding a safe dose and whether it can shrink or control tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your general function is good (ECOG performance status 0–1)
- You have at least one measurable tumor that can be seen on CT scan or MRI (RECIST 1.1)
- You can take medicine by mouth without needing it changed or crushed in a special way
- Your cancer type matches a listed group and you have either no meaningful standard options left (dose escalation) or have had several standard treatments (dose expansion)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SLV-154 for people whose advanced cancer has not responded to standard treatments. The goal is to see if SLV-154 can shrink tumors or slow cancer growth.
This trial tests a new combination treatment (CVL006 plus other drugs) in people with advanced solid tumors that have stopped responding to standard therapies. It aims to see if the combination can shrink tumors and help patients live longer.
This trial tests a new targeted drug (LY4175408) for people with certain advanced solid tumors (lung, endometrial, or triple negative breast cancer) who have already tried standard treatments. The goal is to see if the drug is safe and effective.
This study tests a new experimental drug called QLS5316 for people with advanced solid tumors that have not responded to standard treatments. The drug works like a 'smart bomb'—it seeks out and delivers medicine directly to cancer cells.
This study tests a new drug, CVL006, in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective for certain types of cancer, such as non-small cell lung cancer or tumors with high genetic mutations (MSI-H/dMMR or TMB-H).
This phase 1 trial tests a new drug called SLV-324 for people with solid tumors that have spread and are no longer responding to standard treatments. The goal is to see if the drug is safe and works against the cancer.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.